175 related articles for article (PubMed ID: 22645357)
21. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
22. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.
Lu L; Zhou X; Wang J; Zheng SG; Horwitz DA
PLoS One; 2010 Dec; 5(12):e15150. PubMed ID: 21179414
[TBL] [Abstract][Full Text] [Related]
23. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
[TBL] [Abstract][Full Text] [Related]
24. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
25. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
26. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
28. Pak2 is essential for the function of Foxp3+ regulatory T cells through maintaining a suppressive Treg phenotype.
O'Hagan KL; Miller SD; Phee H
Sci Rep; 2017 Dec; 7(1):17097. PubMed ID: 29213081
[TBL] [Abstract][Full Text] [Related]
29. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
30. Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells.
Baine I; Basu S; Ames R; Sellers RS; Macian F
J Immunol; 2013 Feb; 190(3):1008-16. PubMed ID: 23275607
[TBL] [Abstract][Full Text] [Related]
31. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
32. Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0/G1 arrest mediated by inhibition of Skp2 transcription.
Center DM; Cruikshank WW; Zhang Y
J Immunol; 2004 Feb; 172(3):1654-60. PubMed ID: 14734747
[TBL] [Abstract][Full Text] [Related]
33. Inducible regulatory T cells (iTregs) from recent-onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls.
Glisic S; Ehlenbach S; Jailwala P; Waukau J; Jana S; Ghosh S
Cell Tissue Res; 2010 Mar; 339(3):585-95. PubMed ID: 20143240
[TBL] [Abstract][Full Text] [Related]
34. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
36. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
37. Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans.
Waight JD; Takai S; Marelli B; Qin G; Hance KW; Zhang D; Tighe R; Lan Y; Lo KM; Sabzevari H; Hofmeister R; Wilson NS
J Immunol; 2015 Feb; 194(3):878-82. PubMed ID: 25548231
[TBL] [Abstract][Full Text] [Related]
38. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
39. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
40. The antioncogenic effect of Beclin-1 and FOXP3 is associated with SKP2 expression in gastric adenocarcinoma.
Kim HK; Won KY; Han SA
Medicine (Baltimore); 2021 Aug; 100(33):e26951. PubMed ID: 34414959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
